Sopharma AD notifies that for May 2018 the Company recorded a decrease of sales revenues of 11% compared to the same month of 2017, including 1% increase of domestic sales and a decrease of 16% of export sales.

For the first five months of this year, revenues from sales of products decreased by 2% compared to the same period of 2017, including 1% increase of domestic sales and 3% decrease of export sales.

Sopharma AD notifies that on 4 June 2018 the Company bought 6 600 own shares representing 0.00490% of the share capital of the Company, at a total value of 27900.00 BGN on the Bulgarian Stock Exchange, the average price per share was 4.23 BGN.

The trading of treasury shares is pursuant to decision by the Extraordinary General Meeting of Shareholders from 23 February 2018.

The total number of treasury shares after these transactions is 9 040 766, representing 6.707% of the share capital of the Company.

With deep sorrow we announce that Mr. Andrey Breshkov, a member of the Board of Directors of Sopharma AD, unexpectedly passed away. May he rest in peace!

Until the Company elects a Member of the Board of Directors in accordance with the Commercial Law and the Public Offering of Securities Act, the Board will continue to perform its functions with four members.